Rare diseases
Investigational molecules
Locations
Back to Spain205 clinical trials in Barakaldo, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)SpainA Phase 3 Randomized Study of mRNA‑4157 plus Pembrolizumab as Adjuvant Therapy in Patients with Completely Resected Stage I Non‑Small Cell Lung Cancer
SpainOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
SpainA study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer
SpainStudy of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer
SpainStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
SpainStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
SpainA Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes
SpainA Study of Baricitinib to Delay Type 1 Diabetes in Children and Adults at Risk of Developing the Disease
SpainPhase 3 Study of GSK6042981 versus Imatinib in Adults with Previously Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors (GIST)
SpainA Phase 3 Study of Sapablursen Compared with Placebo in Adults with Polycythemia Vera
SpainA double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on acute cerebral ischemic stroke treatments and groundbreaking studies in Parkinson's disease management, including trials of novel compounds like NEU-411 and CVN424.
These trials aim to improve patient outcomes and develop more effective treatment strategies.
Comprehensive cancer studies including treatments for metastatic prostate cancer, pancreatic adenocarcinoma, and innovative approaches in breast cancer therapy.
Focus on developing targeted therapies and improving survival rates across various cancer types.
Studies addressing COVID-19 vaccination strategies and treatments for invasive candidiasis, with particular attention to antimicrobial therapies.
These trials evaluate new therapeutic approaches and vaccine effectiveness.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
